Connect Biopharm Llc
Clinical trials sponsored by Connect Biopharm Llc, explained in plain language.
-
New shot could tame asthma Flare-Ups
Disease control OngoingThis Phase 2 trial tests whether adding rademikibart (a shot) to standard care can help adults and teens with asthma and type 2 inflammation avoid hospital visits or needing more steroids during an attack. About 160 participants will receive either the drug or a placebo. The main…
Phase: PHASE2 • Sponsor: Connect Biopharm LLC • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New shot aims to tame COPD Flare-Ups in inflammatory subtype
Disease control OngoingThis Phase 2 trial tests whether rademikibart, an injected drug, can help adults with COPD who are having a sudden flare-up and have a specific type of inflammation (type 2). The study will compare the drug to a placebo in 160 participants, looking at whether it reduces treatment…
Phase: PHASE2 • Sponsor: Connect Biopharm LLC • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC